Depo-Medrol vet 40 mg/ml injektioneste, suspensio
Depo-Medrol vet 40 mg/ml injektioneste, suspensio
Authorised
- Methylprednisolone acetate
Product identification
Medicine name:
Depo-Medrol vet 40 mg/ml injektioneste, suspensio
Active substance:
- Methylprednisolone acetate
Target species:
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intraarticular use
-
Intramuscular use
Product details
Active substance and strength:
-
Methylprednisolone acetate40.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intraarticular use
-
Horse
-
Meat and offal28dayValmisteella ei ole tehty jäämäselvityksiä lihaksensisäisellä antotavalla, joten 28 vuorokauden varoaika on riittävä vain käytettäessä valmistetta intra-artikulaarisesti, jännetupin sisäisesti tai periosteaalisesti.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Available in:
-
Finland
Package description:
- Available only in Finnish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
- Pfizer Manufacturing Belgium
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 7629
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 21/05/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Finnish (PDF)
Published on: 21/05/2024
